ACR-368
ACR-368-201 (GOG 3082)
Phase 2 small_molecule active
Quick answer
ACR-368 for Endometrial Adenocarcinoma is a Phase 2 program (small_molecule) at Acrivon Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acrivon Therapeutics
- Indication
- Endometrial Adenocarcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active